These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 762813)

  • 1. Step 2 regimens in hypertension. An assessment.
    Finnerty FA; Gyftopoulos A; Berry C; McKenney A
    JAMA; 1979 Feb; 241(6):579-81. PubMed ID: 762813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in the elderly: review of therapy with a hydroflumethiazide-reserpine combination.
    Elkowitz EB
    J Am Geriatr Soc; 1979 Nov; 27(11):507-10. PubMed ID: 489858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic blockers in the treatment of hypertension--experience with propranolol at Ibadan, Nigeria.
    Olatunde A; Akinkugbe OO; Carlisle R
    East Afr Med J; 1977 Apr; 54(4):194-201. PubMed ID: 902626
    [No Abstract]   [Full Text] [Related]  

  • 5. Duration of effect of single daily doses of reserpine and hydroflumethiazide evaluated by noninvasive technology in hypertensive patients.
    Gifford RW; Williams GW; Vidt DG; Bolen K; Acker C
    Cleve Clin Q; 1982; 49(4):209-18. PubMed ID: 7168911
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe.
    Stein CM; Neill P; Mwaluko GM; Kusema T
    S Afr Med J; 1990 Mar; 77(5):243-5. PubMed ID: 2107581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the use of reserpine versus alpha-methyldopa for second step treatment of hypertension in the elderly.
    Applegate WB; Carper ER; Kahn SE; Westbrook L; Linton M; Baker MG; Runyan JW
    J Am Geriatr Soc; 1985 Feb; 33(2):109-15. PubMed ID: 3968365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol in the treatment of essential hypertension.
    JAMA; 1977 May; 237(21):2303-10. PubMed ID: 323525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertension with a new kind of drug combination].
    Emich R; Roiko G
    Wien Med Wochenschr; 1968 Oct; 118(40):822-5. PubMed ID: 5710853
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug choice for treatment of hypertension at 'step 2'.
    Feigenbaum LZ
    West J Med; 1979 Apr; 130(4):391-3. PubMed ID: 442637
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of antihypertensive therapy on the quality of life.
    Croog SH; Levine S; Testa MA; Brown B; Bulpitt CJ; Jenkins CD; Klerman GL; Williams GH
    N Engl J Med; 1986 Jun; 314(26):1657-64. PubMed ID: 3520318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of single-dose methyldopa and diuretic on BP and left ventricular mass.
    Weinstein M; Hilewitz H; Rogel S
    Arch Intern Med; 1984 Aug; 144(8):1629-32. PubMed ID: 6235790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrochlorothiazide plus methyldopa in the treatment of isolated systolic hypertension in the elderly.
    Boyles PW
    Clin Ther; 1984; 6(6):793-9. PubMed ID: 6509462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug combinations as rational antihypertensive therapy.
    Gifford RW
    Arch Intern Med; 1974 Jun; 133(6):1053-7. PubMed ID: 4151443
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative evaluation of aldactide and methyldopa in the management of benign essential hypertension.
    Nair KG; Jairam HN; Lal HM; Phaterpekar SJ
    J Assoc Physicians India; 1980; 28(1-2):7-13. PubMed ID: 7216969
    [No Abstract]   [Full Text] [Related]  

  • 19. Antihypertensive efficacy of alpha-methyldopa, chlorothiazide and Supres-150 (alpha-methyldopa-chlorothiazide).
    Fernandez PG; Zachariah PK; Bryant DG; Missan SS
    Can Med Assoc J; 1980 Aug; 123(4):284-7. PubMed ID: 7020900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension.
    Yonga GO; Ogola EN; Orinda DA
    East Afr Med J; 1993 Nov; 70(11):696-700. PubMed ID: 8033771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.